Skip to main content
. 2019 Jan 16;8(1):102. doi: 10.3390/jcm8010102

Table 2.

Comparisons of primary and secondary outcomes.

Overall Cohort Propensity-Matched Cohort
Treatment (n = 229) Control (n = 915) p Treatment (n = 227) Control (n = 527) p
28-day mortality 42 (18.3) 160 (17.5) 0.76 42 (18.5) 92 (17.5) 0.84
In-hospital mortality 38 (16.6) 167 (18.3) 0.55 38 (16.7) 97 (18.4) 0.54
ICU LOS (days) 4 (3–8) 4 (3–8) 0.70 4 (3–8) 4 (3–7) 0.84
Hospital LOS (days) 14 (9–22) 13 (8–23) 0.49 14 (9–22) 13 (8–23) 0.33
Duration of mechanical ventilation 6.0 (3.0–15.0) 6.0 (3.0–12.0) 0.61 5.5 (3.0–15.0) 5.0 (3.0–10.0) 0.63
New use of renal replacement therapy 28 (12.3) 106 (11.9) 0.87 28 (12.4) 66 (12.9) 0.51

Data are shown as median (interquartile range) or as n (%). ICU: intensive care unit; LOS: length of stay.